On January 29th, we posted a CotW outlining the top 10 pharma companies by number of unique biomarkers those companies are using in trials. We thought it was about time to update that chart and expand it to the top 25 pharma companies. Interesting facts to note:
- Trials are added and changed so frequently that these numbers will also be changing frequently
- Novartis‘ lead is shrinking
- Pfizer overtakes BI for the second spot
- AstraZeneca made it in to the top 10 – we were surprised when they weren’t there in January
- Celgene holds on to the 9th spot
For a refresher on Amplion and BiomarkerBase:
[plsc_button url=”https://amplion.wpengine.com/biomarkerbase-demo/?hsCtaTracking=f9d217c0-3d3d-4625-adcc-7be5c13cb9be%7C379a477c-1ce0-462d-87d0-ff5cadcfa342″ target=”_blank” color=”green” style=”flat” radius=”square” size=”lg”]REQUEST DEMO[/plsc_button]